SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Camaris C, Little D. J. Forensic Sci. 1997; 42(5): 954-955.

Copyright

(Copyright © 1997, American Society for Testing and Materials, Publisher John Wiley and Sons)

DOI

unavailable

PMID

9304853

Abstract

A fatality due to ingestion of the antidepressant drug moclobemide is reported. Moclobemide is a selective and reversible inhibitor of monoamine oxidase type A. Previous reports have suggested that it is a safe drug even when taken in large quantities. The few reported fatalities have all been ascribed to serotonin syndrome, due to an interaction between moclobemide and other serotonergic agents. A 48-year-old woman with a history of depression and suicide attempts was found deceased at home. Autopsy revealed no evidence of significant natural disease or injury. Toxicologic analysis was performed and drug levels measured by capillary gas chromatography. The blood concentration of moclobemide was 137 mg/L and the liver concentration was 432 mg/kg. Low levels of diazepam, nordiazepam, and trifluoperazine were also detected. Death was considered to be due to acute poisoning by moclobemide. This case report is the first, to our knowledge, where death has been attributed to the toxic effects of moclobemide alone.


Language: en

Keywords

Antidepressive Agents; Benzamides; Diazepam; Fatal Outcome; Female; Flumazenil; Humans; Liver; Middle Aged; Moclobemide; Nordazepam; Trifluoperazine

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print